In the original version of this article (1), The HLA profile in panel B of Fig. 2 was inadvertently mislabeled. The error has been corrected in the online HTML and PDF versions of the article. The authors regret this error.
HLA polymorphisms are associated with treatment-free remission following discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia.
Mol Cancer Ther
©2022 American Association for Cancer Research
American Association for Cancer Research